Heritability Analyses Uncover Shared Genetic Effects of Lung Function and Change over Time

Genes (Basel). 2022 Jul 15;13(7):1261. doi: 10.3390/genes13071261.

Abstract

Genetic influence on lung functions has been identified in previous studies; however, the relative longitudinal effects of genetic factors and their interactions with smoking on lung function remain unclear. Here, we identified the longitudinal effects of genetic variants on lung function by determining single nucleotide polymorphism (SNP) heritability and genetic correlations, and by analyzing interactions with smoking. Subject-specific means and annual change rates were calculated for eight spirometric measures obtained from 6622 Korean adults aged 40−69 years every two years for 14 years, and their heritabilities were estimated separately. Statistically significant (p < 0.05) heritability for the subject-specific means of all spirometric measures (8~32%) and change rates of forced expiratory volume in 1 s to forced vital capacity ratio (FEV1/FVC; 16%) and post-bronchodilator FEV1/FVC (17%) were detected. Significant genetic correlations of the change rate with the subject-specific mean were observed for FEV1/FVC (ρg = 0.64) and post-bronchodilator FEV1/FVC (ρg = 0.47). Furthermore, post-bronchodilator FEV1/FVC showed significant heritability of SNP-by-smoking interaction (hGXS2 = 0.4) for the annual change rate. The GWAS also detected genome-wide significant SNPs for FEV1 (rs4793538), FEV1/FVC (rs2704589, rs62201158, and rs9391733), and post-bronchodilator FEV1/FVC (rs2445936). We found statistically significant evidence of heritability role on the change in lung function, and this was shared with the effects on cross-sectional measurements. We also found some evidence of interaction with smoking for the change of lung function.

Keywords: heritability; likelihood functions; longitudinal study; pulmonary function tests; single nucleotide polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bronchodilator Agents* / pharmacology
  • Cross-Sectional Studies
  • Forced Expiratory Volume / genetics
  • Humans
  • Lung*
  • Middle Aged
  • Vital Capacity / genetics

Substances

  • Bronchodilator Agents

Grants and funding

This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Korean government (MSIT) (2019M3E5D3073365) and by 2020 Research Support Program funded by the Korea Medical Institute. This study was conducted with bioresources from National Biobank of Korea, the Center for Disease Control and Prevention, Republic of Korea. (KBN-2020-093 and KBN-2021-014). Chol Shin was supported by Korea Centers for Disease Control and Prevention (KCDC) grants (Nos. 2001-347-6111-221, 2002-347-6111-221, 2003-347-6111-221, 2004-E71001-00, 2005-E71001-00, 2006-E71005-00, 2006-E71006-00, 2007-E71001-00, 2007-E71003-00, 2008-E71001-00, 2008-E71005-00, 2009-E71002-00, 2009-E71007-00, 2010-E71001-00, 2010-E71004-00, 2011-E71004-00, 2011-E71008-00, 2012-E71005-00, 2012-E71008-00, 2013-E71005-00, 2013-E71007-00, 2014-E71003-00, 2014-E71005-00, 2015-P71001-00, 2015-E71002-00, 2016-E71003-00, 2016-E71002-00), an NRF grant funded by the Korea government (MSIP) (NRF-2017R1A6A3A11034663), and a Korea University Grant. This study was conducted with bioresources from National Biobank of Korea, the Korea Disease Control and Prevention Agency, Republic of Korea (NBK-2020-101).